Dr. Geeta Shroff has developed the technology to isolate human embryonic stem cells (hESC), culture them, prepare them for clinical application, and store them in ready-to-use form with a shelf life of six months. Further, this technology is being used clinically to treat patients. Since 2002, over 1400 patients suffering from various conditions-Spinal cord injury, Diabetes, Multiple sclerosis, Parkinsonís disease, Cardiac conditions, Cerebral palsy - all presently categorized as incurable, have been treated by Dr. Shroff and the number is steadily growing. A graduate in medicine from the University of Delhi, Dr. Shroff did her post graduation in Gynecology & Obstetrics. A qualified IVF practitioner with vast knowledge and experience in embryology, she has been trained in all aspects of human stem cell culture, vitrification and thawing techniques. After gaining 8 years of valuable clinical experience at Safdarjung Hospital & Batra Hospital, both large multi-specialty hospitals in Delhi, Dr. Shroff set up her own IVF practice in 1996. She began research on human embryonic stem cells in 1999, and pioneered human embryonic stem cell therapy. She has presented her work at various national and international forums. Dr. Shroff envisions making hESC therapy available globally so that it becomes the first line of treatment for many of mankindís worst afflictions.
Dr. Shroff's area of interest is stem cell and regenerative medicine.